Lupin Acquires VISUfarma to Grow Eye Health Segment in Europe

Global pharmaceutical giant Lupin Limited disclosed that its wholly owned subsidiary, Nanomi B.V., has executed a definitive agreement to acquire VISUfarma B.V., a specialty eye health company backed by GHO Capital Partners...

Syngene Advances Novel Vascular Calcification Inhibitor API

Syngene International has achieved a successful scale-up of the synthesis of a new active pharmaceutical ingredient for vascular calcification inhibition, progressing from lab-scale proof-of-concept to commercial-scale good manufacturing...

Moderna's mNEXSPIKE Shows Strong Response to LP.8.1 Variant

Moderna has conveyed that the primary immunogenicity data for the 2025-2026 formula of mNEXSPIKE, the mRNA COVID-19 vaccine of their choice to the LP.8.1 variant of SARS-CoV-2, is in the positive range.

HIV Jab for 115 Nations Awaits Nod from Indian Regulators

The revolutionary change that could dramatically impact the prevention of HIV may well hinge on how fast Indian regulators accept the proposal. Gilead Sciences, a US-based company, gave no-royalty licenses to four Indian firms

Pharmexcil, NLDSL Launch Digital Tools to Boost Exports

The Pharmaceuticals Export Promotion Council of India (Pharmexcil) recently held a crucial meeting with the NICDC Logistics Data Services Limited (NLDSL) to launch Logistics e-Marketplace (LeMP) and a new under-development portal search engine regard

AbbVie Submits NDA to FDA for Tavapadon in Parkinson's Treatment

AbbVie announced that it has officially submitted a NDA to the USFDA for tavapadon, a next generation selective dopamine D1/D5 receptor partial agonist created to be taken once daily for oral administration for the treatment of Parkinson's...

Glenmark, Granules, Zydus Recall Drugs in US: USFDA Alert

According to the US Food and Drug Administration (USFDA), products of Glenmark, Granules India, Sun Pharma, Zydus, and Unichem have been voluntarily recalled in the United States due to manufacturing deficiencies.

India to Launch Novo Nordisk's Ozempic Amid Obesity Surge

Danish pharmaceutical giant Novo Nordisk is planning to introduce Ozempic (semaglutide) in India, a once-weekly injectable that was initially approved for type-2 diabetes but is getting recognition as a treatment for obesity

FUJIFILM India Launches Digital X-Ray Facility in Dholera

FUJIFILM India, a worldwide leader in healthcare technology, has opened an advanced digital radiology X-Ray facility at the Community Health Centre (CHC) in Dholera. This initiative, part of the company's CSR initiative, is intended to address...

Zydus, Pinkathon Launch 10th Mumbai Run for Awareness

Pinkathon, India's largest women's run, and Zydus Lifesciences Ltd., a global healthcare organization driven by innovation, announced the 10th Mumbai Pinkathon, which would take place at MMRDA Grounds, BKC, on December 21, 2025. Zydus has partnered

on the deck


Most Viewed

Editor's Guest


© 2025 India Pharma Outlook. All Rights Reserved.